ASPI vs DD vs AVY Stock Comparison

ASP Isotopes, DuPont de Nemours and Avery Dennison Prices as of Oct 26, 2026 Peers: Industry group
ASPI ASP Isotopes Inc.
$2.02 -30.8% 1M -79.4% 1Y
Market cap
$253.41M
P/E
–
Revenue (TTM)
$30.85M
Div. yield
–
Specialty Chemicals Basic Materials
1 win
DD DuPont de Nemours, Inc.
$136.27 +3.4% 1M +302.0% 1Y
Market cap
$18.68B
P/E
339.6x
Revenue (TTM)
$6.99B
Div. yield
0.02%
Specialty Chemicals Basic Materials
5 wins
AVY Avery Dennison Corp
$183.42 +7.7% 1M +1.0% 1Y
Market cap
$13.85B
P/E
19.6x
Revenue (TTM)
$9.25B
Div. yield
0.02%
Specialty Chemicals Basic Materials
6 wins

Head to Head

12 decided of 12

Avery Dennison leads on 6 of the 12 questions below (Avery Dennison 6, DuPont de Nemours 5, ASP Isotopes 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionASPIDDAVYLeader
Larger companyMarket capitalisation $253.41M $18.68B $13.85B DD
Cheaper on earningsLower P/E, profitable companies only -2.2x 339.6x 19.6x AVY
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 20.1x 17.3x AVY
Faster revenue growthRevenue growth, trailing twelve months +573.4% +3.3% +5.8% ASPI
More profitableNet margin, trailing twelve months -380.3% 0.8% 7.6% AVY
Better return on capitalReturn on invested capital -28.6% 8.8% 14.3% AVY
Less leveragedLower net debt / EBITDA 2.1x 0.7x 2.3x DD
Higher dividend yieldTrailing dividend yield 0.00% 0.02% 0.02% DD
Better 1-year returnPrice return, last 12 months -79.4% +302.0% +1.0% DD
Better 5-year returnAnnualised price return, 5 years — +36.4%/yr -2.5%/yr DD
Less volatileAnnualised volatility, 1 year 99.0% 114.1% 23.5% AVY
Higher overall scoreMean of the five percentile scores vs peers 26/100 54/100 69/100 AVY

Percentile Scorecard

ASPIDDAVY

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisASPIDDAVY
Valuation 9 #86 of 94 57 #41 of 94 60 #38 of 94
Growth 19 #75 of 92 45 #51 of 92 84 #16 of 92
Profitability 8 #82 of 89 73 #25 of 89 93 #7 of 89
Financial Health 69 #31 of 97 76 #24 of 97 33 #65 of 97
Shareholder Returns – 19 #57 of 70 77 #17 of 70
Overall 26 54 69
  • ASPI ranked among 99 companies in Chemicals
  • DD ranked among 99 companies in Chemicals
  • AVY ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodASPIDDAVYSPY
1 month -30.8%+3.4%+7.7% -0.8%
3 months -50.1%-2.6%+12.5% +3.5%
6 months -64.2%+191.9%+11.2% +7.0%
Year to date -62.2%+239.0%+0.8% +12.2%
1 year -79.4%+302.0%+1.0% +13.0%
3 years +98.0%+351.4%+7.6% +86.3%
3 years, per year +25.6%+65.3%+2.5% +23.1%
5 years —+371.0%-11.9% +68.6%
5 years, per year —+36.4%-2.5% +11.0%
10 years —+325.7%+158.5% +258.0%
10 years, per year —+15.6%+10.0% +13.6%

Risk

MeasureASPIDDAVYSPY
Volatility, 1Y 99.0%114.1%23.5% 12.7%
Downside volatility, 1Y 99.5%26.6%21.7% 12.7%
Beta vs S&P 500, 1Y 3.891.580.48 1.00
Return / volatility, 1Y -0.802.650.04 1.02
Max drawdown, 5Y -88.6%-41.1%-33.3% -25.4%
From 52-week high -81.2%-7.4%-7.1% -1.8%
52-week high $10.76$147.23$197.45 $779.14
52-week low $1.95$34.05$153.01 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleASPIDDAVY
P/E now vs peer median -2.1xmedian 21.6x 336.7xmedian 21.6x 19.9xmedian 21.6x
P/S now vs peer median 8.5xmedian 1.4x 2.6xmedian 1.4x 1.5xmedian 1.4x
EV/EBITDA now vs peer median -0.7xmedian 12.4x 9.5xmedian 12.4x 11.4xmedian 12.4x
P/FCF now vs peer median -3.1xmedian 15.8x 26.2xmedian 15.8x 13.1xmedian 15.8x
P/B now vs peer median 1.0xmedian 1.6x 1.3xmedian 1.6x 6.0xmedian 1.6x
PEG now vs peer median 0.06median 1.66 -4.40median 1.66 2.05median 1.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsASPIDDAVY
Revenue $30.85M $6.99B $9.25B
Gross profit $5.65M $2.46B $2.68B
Operating income -$99.07M $1.63B $1.19B
Net income -$117.34M $62.00M $704.90M
Free cash flow -$83.58M $702.00M $1.06B
R&D $22.04M $18.00M –
EPS (diluted) $-0.96 $0.40 $9.23
Cash & equivalents $219.60M $1.74B $227.30M
Total debt $59.77M $3.13B $14.80B
Shares (diluted) 122.72M 136.80M 76.40M
Enterprise value -$733.30M $13.56B $12.62B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricASPIDDAVY
P/E -2.1x 336.7x 19.9x
P/FCF -3.1x 26.2x 13.1x
P/Operating cash flow -3.9x 17.7x 11.3x
P/S 8.5x 2.6x 1.5x
P/B 1.0x 1.3x 6.0x
P/Tangible book 1.0x 1.7x 9.0x
EV/EBITDA -0.7x 9.5x 11.4x
EV/EBIT -0.7x 12.1x 14.6x
EV/Revenue 2.2x 2.8x 1.9x
EV/FCF -0.8x 28.2x 16.3x
EV/Operating cash flow -1.0x 19.0x 14.1x
PEG (3Y EPS CAGR) 0.06 -4.40 2.05

Growth

14 metrics
MetricASPIDDAVY
Revenue growth (1Y) 573.4% 3.3% 5.8%
Revenue CAGR (3Y) 2,420% -17.7% 2.9%
Gross profit growth (1Y) 214.3% 7.6% 7.4%
Gross profit CAGR (3Y) – -17.5% 6.6%
Operating income growth (1Y) -200.2% 8.0% 5.9%
Operating income CAGR (3Y) -105.1% -13.0% 8.9%
Net income growth (1Y) -17.1% 136.0% -0.9%
Net income CAGR (3Y) -119.1% -76.5% 7.6%
EPS growth (1Y) 30.3% 129.1% 1.6%
EPS CAGR (3Y) -37.1% -76.4% 9.7%
Operating cash flow growth (1Y) -244.7% 1,101% 51.6%
Operating cash flow CAGR (3Y) -151.6% -12.8% 17.6%
Free cash flow growth (1Y) -182.5% 378.6% 67.3%
Free cash flow CAGR (3Y) -123.3% -7.9% 31.2%

Profitability

14 metrics
MetricASPIDDAVY
Gross margin 18.3% 35.1% 29.0%
EBITDA margin -303.3% 29.7% 16.5%
Operating margin -321.1% 23.4% 12.8%
Pretax margin -443.4% 6.8% 10.4%
Net margin -380.3% 0.8% 7.6%
FCF margin -270.9% 10.0% 11.5%
Operating cash flow margin -219.8% 14.9% 13.3%
Return on equity -40.9% 0.6% 30.5%
Return on assets -20.2% 0.4% 7.8%
Return on invested capital -28.6% 8.8% 14.3%
Return on capital employed -19.4% 8.5% 19.5%
Asset turnover 0.1x 0.3x 1.0x
Cash conversion (OCF / net income) 0.6x 16.8x 1.8x
Stock comp / revenue 60.5% 0.6% 0.3%

Financial Health

11 metrics
MetricASPIDDAVY
Debt / assets 10.4% 14.8% 39.9%
Debt / equity 0.2x 0.2x 1.6x
Net debt / EBITDA 2.1x 0.7x 2.3x
Debt / FCF -0.7x 4.5x 3.5x
Liabilities / assets 52.0% 34.1% 74.8%
Equity / assets 48.0% 65.9% 25.2%
Interest coverage -25.3x 7.2x 8.4x
Current ratio 3.9x 2.4x 1.1x
Quick ratio 3.7x 1.7x 0.7x
Cash ratio 3.6x 0.9x 0.1x
Altman Z-score -0.23 0.67 3.58

Shareholder Returns

7 metrics
MetricASPIDDAVY
Dividend yield – 1.8% 2.1%
Net buyback yield – -0.7% 2.9%
Shareholder yield – 1.0% 5.1%
Payout ratio (earnings) – 672.6% 41.7%
Payout ratio (FCF) – 59.4% 27.7%
Dividend growth (1Y) – -36.9% 3.4%
Dividend CAGR (3Y) – -13.6% 5.9%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusASPIDDAVY
Forward P/E – 20.1xFY2026 17.3xFY2026
EPS, next fiscal year $-0.45FY2026 $6.77FY2026 $10.61FY2026
EPS growth, next FY – +34.3%FY2026 +11.3%FY2026
EPS growth, the year after – +22.6% +7.9%
Revenue, next fiscal year $24.34MFY2026 $7.32BFY2026 $9.82BFY2026
Revenue growth, next FY +2.0%FY2026 +6.9%FY2026 +10.9%FY2026
Revenue growth, the year after +189.0% +7.2% +0.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersASPIDDAVY
Held by institutions 50.3% 73.0% 97.4%
Institutions holding 186 1,118 783
Change in shares held, QoQ +3.3% -5.7% +2.7%
Institutions buying 113 1,090 384
Institutions selling 53 27 272
Buyers to sellers 2.13 40.37 1.41

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ASPIDDAVY
ASPI 1.00 0.16 0.04
DD 0.16 1.00 0.08
AVY 0.04 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ASPI, DD and AVY?

DuPont de Nemours (DD) is the largest by market capitalisation: ASP Isotopes (ASPI) $253.41M, DuPont de Nemours (DD) $18.68B, Avery Dennison (AVY) $13.85B.

Which stock is cheaper, ASPI, DD and AVY?

Avery Dennison (AVY) trades on the lowest price-to-earnings ratio (ASP Isotopes (ASPI) -2.2x, DuPont de Nemours (DD) 339.6x, Avery Dennison (AVY) 19.6x). On next year's consensus earnings, Avery Dennison (AVY) is cheapest (DuPont de Nemours (DD) 20.1x, Avery Dennison (AVY) 17.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

ASP Isotopes (ASPI) grew revenue fastest over the trailing twelve months: ASP Isotopes (ASPI) +573.4%, DuPont de Nemours (DD) +3.3%, Avery Dennison (AVY) +5.8%.

Which company is more profitable?

Avery Dennison (AVY) has the highest net margin (ASP Isotopes (ASPI) -380.3%, DuPont de Nemours (DD) 0.8%, Avery Dennison (AVY) 7.6%). On return on invested capital, Avery Dennison (AVY) leads (ASP Isotopes (ASPI) -28.6%, DuPont de Nemours (DD) 8.8%, Avery Dennison (AVY) 14.3%).

Which stock has performed better?

Over the past year DuPont de Nemours (DD) returned the most: ASP Isotopes (ASPI) -79.4%, DuPont de Nemours (DD) +302.0%, Avery Dennison (AVY) +1.0%. Over five years, DuPont de Nemours (DD) compounded fastest (DuPont de Nemours (DD) +36.4%/yr, Avery Dennison (AVY) -2.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

DuPont de Nemours (DD) has the highest dividend yield: ASP Isotopes (ASPI) 0.00%, DuPont de Nemours (DD) 0.02%, Avery Dennison (AVY) 0.02%. ASP Isotopes (ASPI) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Avery Dennison (AVY) has been the steadiest (ASP Isotopes (ASPI) 99.0%, DuPont de Nemours (DD) 114.1%, Avery Dennison (AVY) 23.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ASPI, DD and AVY?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Avery Dennison (AVY) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.